GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] we are measuring EU at the wrong time and calling it noise — 21 comments in the full submission. View in context.
541
c/glp1eu·submitted 8 months ago by u/nl_verzekering

[Discussion] we are measuring EU at the wrong time and calling it noise

Discussionbranch of 7 comments

Thinking out loud about this: we are measuring EU at the wrong time and calling it noise. Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product. Nothing here is medical or legal advice, and eligibility questions have national…

Read the full submission and all 21 comments →

This branch

7 comments, started 8 months ago
u/solene_ilunga7 points·8 months ago

This. The published reimbursement criteria are the document to read, and most member states do publish them.

replysharereportpermalink
u/ewan_tulloch10 points·8 months ago

Read the published reimbursement criteria where I live rather than asking. Took twenty minutes and answered everything.

replysharereportpermalink
u/nordic_pricing7 points·8 months ago

the language barrier is a real cost and nobody budgets for it

replysharereportpermalink
u/zaid_eriksen2 points·8 months ago

That shortage notice was national and does not apply where the question is coming from.

replysharereportpermalink
u/nl_verzekeringOP1 point·8 months ago

Correcting myself upthread: the criterion I quoted was updated for this year.

replysharereportpermalink
u/osman_brandt3 points·8 months ago

Yes — keep both the prescription and the receipt. Claims processes ask for both and never at a convenient moment.

replysharereportpermalink
u/kaplan_meier_kim2 points·8 months ago

a shortage in one member state is not a shortage in all of them

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/glp1eu
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/eu_apotheke_au/nl_verzekeringu/nordic_pricingu/spain_receta
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →